Incidence, characterization, and impact of newly detected donor-specific anti-HLA antibody in the first year after pediatric heart transplantation: A report from the CTOTC-04 study.

MLA

Dipchand, A. I., et al. “Incidence, Characterization, and Impact of Newly Detected Donor-Specific Anti-HLA Antibody in the First Year after Pediatric Heart Transplantation: A Report from the CTOTC-04 Study.” American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons, vol. 18, no. 9, Sept. 2018, pp. 2163–74. EBSCOhost, https://doi.org/10.1111/ajt.14691.

APA

Dipchand, A. I., Webber, S., Mason, K., Feingold, B., Bentlejewski, C., Mahle, W. T., Shaddy, R., Canter, C., Blume, E. D., Lamour, J., Zuckerman, W., Diop, H., Morrison, Y., Armstrong, B., Ikle, D., Odim, J., & Zeevi, A. (2018). Incidence, characterization, and impact of newly detected donor-specific anti-HLA antibody in the first year after pediatric heart transplantation: A report from the CTOTC-04 study. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 18(9), 2163–2174. https://doi.org/10.1111/ajt.14691

Chicago

Dipchand, A I, S Webber, K Mason, B Feingold, C Bentlejewski, W T Mahle, R Shaddy, et al. 2018. “Incidence, Characterization, and Impact of Newly Detected Donor-Specific Anti-HLA Antibody in the First Year after Pediatric Heart Transplantation: A Report from the CTOTC-04 Study.” American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 18 (9): 2163–74. doi:10.1111/ajt.14691.